Current Therapeutic Approaches for Early-Stage HER2-Positive Breast Cancer

Download All
Download this slideset with key data on optimal adjuvant therapy and extended adjuvant therapy for patients with early-stage HER2-positive breast cancer. Experts discuss how to identify which patients are most likely to benefit from the available treatment strategies.
Sara Hurvitz, MD, FACP
Hope S. Rugo, MD

Downloadable Slideset

Download these slides from our live meeting series on treatment strategies for HER2+ EBC to review the current clinical rational and most recent data on HER2-targeted for patients with early stage HER2+ breast cancer.

Sara Hurvitz, MD, FACP Hope S. Rugo, MD Released: April 25, 2019
Provided by Postgraduate Institute for Medicine
PIM Logo

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Puma Biotechnology, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue